Quarterly net sales increased 18 percent compared to the prior year period to a record $486 million on strong demand in Commercial Trailer Products Record quarterly operating income of $33.9 million, up 11 percent compared to the prior year quarter Earnings per diluted share improved 15 percent from prior year to $0.23 per diluted share Full year trailer shipment guidance increased to a range of 53,000 to 55,000 trailers, reflecting the continued strong demand and outlook in the core dry van trailer market
LAFAYETTE, Ind., July 29, 2014 (GLOBE NEWSWIRE) -- Wabash National Corporation (NYSE:WNC) , a diversified industrial manufacturer and North America's leading producer of semi-trailers and liquid transportation systems, today reported results for the second quarter ended June 30, 2014.
Sign-up for RenaissanceRe Reports Net Income of $120.8 Million for the Second Quarter of 2014 or $2.95 Per Diluted Common Share; Quarterly Operating Income of $93.6 Million or $2.28 Per Diluted Common Share investment picks
SAN FRANCISCO (MarketWatch) - Twitter Inc. (TWTR) on Tuesday reported a second-quarter loss of $144.6 million, or 24 cents a share, compared with a loss of $42.2 million, or 32 cents a share for the year-earlier period.
SAN DIEGO , July 29, 2014 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX) today announced that it has closed its previously announced initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share.
Cloud Peak Energy Inc. (NYSE:CLD), one of the largest U.S. coal
producers and the only pure-play Powder River Basin (“PRB”) coal
company, today announced results for the second quarter and first six
months of 2014.
The Board of Directors of Ameriprise Financial, Inc. (NYSE: AMP) has
declared a quarterly cash dividend of $0.58 per common share payable on
August 22, 2014 to shareholders of record at the close of business on
August 11, 2014.
SAN DIEGO , July 29, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company that provides innovative genetic analysis solutions, and Mayo Medical Laboratories (MML), the third-largest provider of esoteric laboratory services in the United States , have announced a license agreement for noninvasive prenatal testing patents and applications.
62% Revenue Growth as Reimbursement and Testing Volumes Improve SAN DIEGO , July 29, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013.
BASKING RIDGE, N.J. , July 29, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO) , a biopharmaceutical company focused on the Phase 3 clinical development of Revolixys™ Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug system, today announced that it will hold a conference call and live audio webcast on Tuesday, Aug.
SAN FRANCISCO , July 29, 2014 /PRNewswire/ -- Digital Realty Trust, Inc. (NYSE: DLR) , a leading global provider of data center and colocation solutions, announced today financial results for the second quarter of 2014.
- Total reportable segment and Other Businesses income from operations of $132 million - Net loss of $18 million, or $0.12 per diluted share and adjusted net income of $25 million, or $0.17 per diluted share
- Cash from operations of $0.8 billion; total liquidity of $3.2 billion, including $1.5 billion of cash PITTSBURGH , July 29, 2014 /PRNewswire/ -- United States Steel Corporation (NYSE: X) reported second quarter 2014 net loss of $18 million , or $0.12 per diluted share, compared to a second quarter 2013 net loss of $78 million , or $0.54 per diluted share, and first quarter 2014 net income of $52 million, or $0.34 per diluted share.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.